1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6032216ACBD35F6AB652578B8003D13E3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/032216ACBD35F6AB652578B8003D13E3!OpenDocument
18
19OpenDocument
2044.201.97.138
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Product Launch » Market Entry: Metabolic and Cardiovascular Diseases

Complimentary Excerpt: Physician Factors that Shape a Successful Metabolic Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies

DB Image

Excerpt in Cart

ID: MD-249


Features:

17 Info Graphics

21 Data Graphics

170 Metrics

9 Narratives


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".


To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5137 "Physician Factors that Shape a Successful Metabolic Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies."


Industries Profiled:
Pharmaceutical; Biotech; Medical Device; Health Care; Chemical; Manufacturing; Consumer Products; Diagnostic; Media


Companies Profiled:
Abbott Laboratories; Amgen; Actelion; AstraZeneca; GlaxoSmithKline; Bristol-Myers Squibb; Roche; Lilly; Novartis; Merck; Genentech; MedImmune; Bayer; Cephalon; Inc.; Teva Neuroscience; Novo Nordisk; Amylin; Laboratorios Deramtologicos Darier; IDS Canada; UCB Pharma; Quintiles; Ther-Rx; ProCaps Laboratories; Baxter Healthcare; Synapse biomedical; Talecris; Eisai; Shire; Takeda Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.